Form 4 Filing for Aquestive Therapeutics, Inc.

This filing details a stock option grant to Marco Taglietti, a director at Aquestive Therapeutics, Inc. The option, for 50,500 shares of Common Stock, was granted on June 10, 2026, with an exercise price of $3.99 and an expiration date of June 10, 2036. The underlying shares vest 100% on June 10, 2027, contingent upon Taglietti's continued service. The filing also includes a Power of Attorney, authorizing representatives to execute and file necessary SEC documents, including Forms 3, 4, 5, and 144, on behalf of the reporting owner.